Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Juliet E. Bryant, Andrew S. Azman, Matthew J. Ferrari, Benjamin F. Arnold, Maciej F. Boni, Yap Boum, Kyla Hayford, Francisco J. Luquero, Michael J. Mina, Isabel Rodríguez-Barraquer, Joseph T. Wu, Djibril Wade, Guy Vernet, Daniel T. Leung
Abstract
Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual-level vs. population-level).
Topics & Concepts
SerologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyPath (computing)BiologyMedicineComputer scienceImmunologyAntibodyComputer networkPathologyDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies